sumit ranjan

Blatant violation of FSSAI order and Delhi High Court order. You do not reply to my mails. So, tagging you here Sir. CEO Shri Rajit Punhani ji @fssaiindia @JPNadda @MoHFW_INDIA @narendramodi @NITIAayog

The Lenskart Cover-Up A $5.6 billion company. A written policy. Two fired employees. A CEO whose story kept changing. Lenskart — India's largest eyewear retailer, IPO-bound, valued at $5.6 billion — had a Style Guide for store staff. It surfaced on April 15. The rules: No bindi. No tilak. No kalawa. Minimal sindoor, not on the forehead. The hijab? Explicitly permitted. With colour instructions. And tutorial videos promised to staff. When the document went viral, CEO Peyush Bansal called it "inaccurate." X's Community Note corrected him — the document was company-branded, dated February 2026. He then shifted: it was an "outdated training document" with an "incorrect line" that was "discovered and removed on February 17, well before this became public." That story collapsed within 24 hours. Akash Falake, a Lenskart store manager in Pune, had emails. He had flagged the exact same policy to Lenskart HR in writing on November 25, 2025. Senior HR was informed again on December 8. Through January and February 2026, store audits were actively cutting salaries of employees who wore bindis or tikas. Falake escalated to the legal team. No response. On February 20, he filed a complaint on Maharashtra's government grievance portal. The same day — he was terminated. Then came Zeel Soghasia from Surat. Got a Lenskart job offer. Flew to Navi Mumbai for training. Day one: told to cut his shikha, remove his tilak and religious tattoos — or there would be no job. He refused. Fired the next day. This was April 18, 2026 — sixty days after Bansal claimed the policy had been removed. Two employees raised this internally over five months. Both were ignored. One was fired the day he went to the government. One was fired for refusing to alter a religious symbol on his body. The CEO's story changed three times. Each time, new evidence forced the shift. This is how institutional discrimination works in the modern Indian workplace — not through speeches, but through audit deductions, grooming guides, and termination letters. Systems designed to be absorbed quietly. It almost worked. Until someone leaked a PDF.

So @TCS is now planning to change its name to Tata Conversion Services? After the #Nashik corporate jihad, now it is the case of a religious conversion in Chennai.

Rainmatter started in 2016, with a few of us doubling up on our day jobs and trying to help startups that were trying to expand India’s capital markets ecosystem. Nine years later, it has grown into something far bigger than we ever imagined. So far, we’ve invested over ₹1,500 crore across 160+ startups spanning fintech, climate, health, media, and deep tech. We’ve also earmarked 10% of everything Zerodha earns to invest in startups, and another 10% for the social sector through the @RainmatterOrg. The thesis has evolved from just expanding the capital markets, but the thread running through it is simple. As a country, we need to own more of what we consume. Sovereignty, in the truest sense. We’re not a typical VC. We don’t take board seats, and we’re not in this for quick exits. We’re not interested in forcing founders into short-term decisions just so we can make money in five or six years. The simple reality is that building a good business is hard. Building one that is genuinely useful, scalable, and profitable is even harder when investors are pushing you to speedrun success and sustainability. That kind of pressure usually leads to shortcuts. And shortcuts, more often than not, come at the consumer’s expense. So our approach has been simple: be patient, back founders for the long term, and help them build the business the right way. That, more than anything else, is the heart of @Rainmatterin.

Asked someone from the industry whether foreign investors are still interested in allocating to India. The TLDR: Interest has pretty much died out. India is seen as geopolitically exposed, especially to an oil shock. There are no real AI plays. Valuations are rich. And the rupee situation doesn't help. On top of that, investors who were sitting on gains have taken money off the table and are now looking at markets like Japan, Taiwan, Korea, Europe etc instead. He also pointed out that our LTCG/STCG structure and the increase in STT have made India less attractive compared to other markets that are seeing inflows. If we need to attract FPIs back, and we do, fixing this feels like pretty low-hanging fruit.

So, Nepal has launched an "Accountability" website. Citizens can track government projects, costs & timelines, etc. on the website. Nepal seems to be doing everything right these days !

FSSAI वालों ने जब हमारे टीम पर FIR किया तो लोगों का आपार जन समर्थन मिला। आप सभी लोगों को हृदय से धन्यवाद। बाकी FSSAI ने FIR क्यों किया पूरा वीडियो देखकर बारीकी से पूरे मामले को समझे और FSSAI को रगड़ते रहे।

I recently had dinner with Dr Devi Shetty, the founder of Narayana Hospitals. For those who don't know him, he's the guy who figured out how to do open heart surgery for a few hundred dollars when the same procedure costs a bomb in the US. Narayana has 18,000 beds across India, and if you ask most middle-class people in Bangalore about it, they'll speak highly of it. There was one thing I kept thinking about over and over again after meeting him. Narayana's market cap is around ₹38,000 crore. Now compare that to pretty much any half-decent financial services business in India, and it'll be valued more than that, including Zerodha. A brokerage, worth more than a hospital chain, that has probably saved hundreds of thousands of lives. I get the arguments. If you're a fund manager/analyst, you can immediately explain it away using margins, capex, asset-light vs asset-heavy, and all that, and I'm not saying the market is wrong. But it's still a strange world we've built, where the businesses closest to money get valued the highest, and the ones doing the hard and essential things get priced like boring utilities. A hospital carries physical infrastructure, enormous liability, thin margins and the actual weight of keeping people alive. And somehow that's worth less than a platform for buying and selling stocks. I don't have a clean take on this. All of this just felt odd. Ps: Nothing here is investment advice. For that, go to @zerodhavarsity

📍 हैदराबाद, FSSAI वालों बताओ जो तुमने पिछले हफ्ते 4 हजार किलो करीब 22 लाख रुपए का नकली गार्लिक पेस्ट पकड़ा था। उन लोगों पर क्या कार्यवाही हुई और अगर नहीं हुई तो कितने रुपए में मामला सेटल कर दिया ?

FSSAI वालों जरा बताओ कि ये कौन सी कम्पनी का केक तैयार किया जा रहा है ?? अगर ना बता पाओ तो ये महिला बार -बार हाइजीन पर सवाल उठा रहीं हैं, इसपर FIR कराकर इसको जेल में डालो।

Is your hospital playing games with you? An unconscious patient billed for 52 litres of mineral water. A routine gallbladder surgery that cost nearly double the estimate. Two children who died of dengue, each billed ₹16 lakh, with consumables marked up 1,700%. These aren't anomalies. They are the system and its red flags. In this video, Abantika Ghosh pulls back the curtain on how, in many hospitals, billing has turned into a profit engine where management teams track every piece of equipment used in your surgery to maximise the invoice, where doctors have lost the discretion to protect you even if they want to, where the word "cancer" is deployed like a weapon to shut down questions, and where being insured is not a safety net but a signal to charge more. It's a warning sign for the red flags you need to watch out for. If you have encountered similar horror stories, let us know in the comments section.

We are pleased to inform everyone that we have filed a complaint against FSSAI before the NHRC. Very soon, notices may reach the concerned FSSAI officials. This is only the first one, and now they may have to answer at multiple places.

📍 अकोला , महाराष्ट्र हाथगाड़ी संचालक नाले का पानी ले जा रहे है नाश्ता बनाने के लिए। सबसे आश्चर्यजनक बात ये है कि लोग सैकड़ों इसी पानी से तैयार हुए नाश्ते को खाते है। खबरदार इसके लिए किसी ने FSSAI और लोकल एजेंसी को जिम्मेदार ठहराया तो।

अस्पताल की मालकिन ने मरीजों को ज्यादा समय तक ICU में भर्ती करने के लिए कह दिया तो इस स्वार्थी महिला डॉक्टर ने इस्तीफा दे दिया। अरे भाई गोरखधंधे में इतना तो चलता है, ऐसे अनप्रोफेशनल डॉक्टर का लाइसेंस रद्द होना चाहिए।

डॉक्टर कह रही हैं कि अस्पताल की मालकिन का कहना है कि ज़्यादा से ज़्यादा मरीजों को ICU में भर्ती करवाओ, इन मैडम को मरीजों का दर्द तो दिखा लेकिन मालकिन का जो दूसरा अस्पताल बन रहा है उसका लिंटर पड़ना है उस पैसे का दर्द नहीं दिखा। छी!!!

ड्रग ऑथोरिटी ऑफ इंडिया, टीम खुरपेंच को मजबूर ना करो। दवाओं के दाम पर रोक लगाओ। एक्सपायर दवा बेचने वालों पर सख्त कार्यवाही करो। ओवरप्राइसिंग, फर्जी बिलिंग, नकली दवाओं और मेडिकल दुकानों की मनमानी पर तुरंत कार्रवाई करो। जनता की जान से खिलवाड़ बंद कराओ। दवा कंपनियों , डिस्ट्रीब्यूटर्स, अस्पतालों और मेडिकल स्टोर्स की जवाबदेही तय करो। रेगुलर इंस्पेक्शन , सैंपल टेस्टिंग और पब्लिक रिपोर्टिंग अनिवार्य करो। जो लोग मरीजों को लूट रहे हैं , उनके लाइसेंस रद्द करो और कानूनी कार्रवाई करो। वरना जिस दिन देश के नागरिकों का सब्र टूट गया, फिर तुमलोग भी FSSAI की तरह FIR FIR खेलते रहना।

एक ही देश में एक ही बीमारी, एक ही दवा , एक ही टेस्ट, एक ही मशीन , फिर दाम इतने अलग-अलग क्यों? क्या मरीज की मजबूरी को market opportunity बना दिया गया है? क्या अस्पताल, लैब, pharma कंपनियां और middlemen मिलकर मनमानी वसूली कर रहे हैं? क्या कोई real-time rate monitoring है भी या नहीं? NPPA, Drug Controller, Health Department और state authorities आखिर कर क्या रहे हैं?

कुछ दिन पहले डॉक्टर अनुज ने कैंसर की महंगी दवाओं का मुद्दा उठाया गया था। अब ज़िम्मेदार अथॉरिटीज़ बताएं कि आपने अब तक क्या कार्रवाई की? सीधी बात सुनिए👇 डॉ. अनुज के मुताबिक Paclitaxel जैसी ज़रूरी दवा, जो दुकानदार को करीब ₹600 में पड़ती है, उसकी MRP ₹12,000 तक रखी जाती है। एक मरीज़ को कई बार 20–30 वायल तक चाहिए होती हैं। यानी बीमारी से लड़ने से पहले ही जेब काट दी जाती है। और यह सिर्फ़ एक दवा की कहानी नहीं है। ज़्यादातर कीमोथेरेपी दवाओं में यही खेल चल रहा है। 200% मुनाफा भी बहुत है, लेकिन 1900% मुनाफा वो भी कैंसर जैसी बीमारी में सीधी इंसानियत की हत्या है। अब सवाल बिल्कुल साफ़ हैं 🔥 दवाओं की कीमतों पर सख्त नियंत्रण क्यों नहीं? NPPA और Drug Controller आखिर कर क्या रहे हैं? क्या इलाज अब सिर्फ़ अमीरों के लिए बचा है? क्या मुनाफा इंसानी जान से बड़ा हो गया है? क्या व्यवस्था यही चाहती है कि लोग बीमारी से कम, दवा खरीदते-खरीदते ज़्यादा मरें? आज की सच्चाई यही है👇 कैंसर से कम , दवा माफिया से ज़्यादा लोग तबाह हो रहे हैं। यह इलाज नहीं , बीमारी के नाम पर खुली लूट है। कब रुकेगा यह खेल? और इसकी जवाबदेही कौन लेगा?

🚨 YOUNG DOCTOR : I am quitting my job. "I was asked by my female boss to admit nearly every patient, even when it was not required" 😳 "ICU stays were stretched to increase hospital bills" "No salary is bigger than ethics & patient safety"

~एक समय था जब हमें सरकारी स्कूल में किताबे मिलती थी। ~उस दिन की खुशी, वो नई किताबें, उनमें कवर चढ़ाना, ~आजकल तो ये सिर्फ धंधा बन चुका है, ~ऐसा क्या प्रिंट होता है इनमें जो किताबें 500 रुपए की होती हैं? ~सरकार इन पर लगाम क्यों नहीं लगाती हैं?